Sign Up Today and Learn More About NGM Biopharmaceuticals Stock
Invest in or calculate the value of your shares in NGM Biopharmaceuticals or other pre-IPO companies through EquityZen's platform.
NGM Biopharmaceuticals Stock
NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.
About NGM Biopharmaceuticals Stock
Founded
2007
Headquarters
South San Francisco, CA, US
Total Funding
295M
Industries
Software, Artificial Intelligence, Data and Analytics
NGM Biopharmaceuticals Press Mentions
Stay in the know about the latest news on NGM Biopharmaceuticals
These South Bay and Peninsula cities are raking in venture capital
TechCrunch • Jul 08, 2017
NGM Biopharmaceuticals Management
Leadership team at NGM Biopharmaceuticals
Vice President, Research
Hui Tian
Vice President, Business Development
Aetna Wun Trombley
Join now and verify your accreditation status to gain access to:
- NGM Biopharmaceuticals Current Valuation
- NGM Biopharmaceuticals Stock Price
- NGM Biopharmaceuticals Management
- Available deals in NGM Biopharmaceuticals and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- NGM Biopharmaceuticals Cap Table and Funding History by Share Class and Liquidity Preferences
- NGM Biopharmaceuticals Revenue and Financials
- NGM Biopharmaceuticals Highlights
- NGM Biopharmaceuticals Business Model
- NGM Biopharmaceuticals Risk Factors
- NGM Biopharmaceuticals Research Report from SACRA Research
Trading NGM Biopharmaceuticals Stock
How to invest in NGM Biopharmaceuticals stock?
Accredited investors can buy pre-IPO stock in companies like NGM Biopharmaceuticals through EquityZen funds. These investments are made available by existing NGM Biopharmaceuticals shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell NGM Biopharmaceuticals stock?
Shareholders can sell their NGM Biopharmaceuticals stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."